drugset / Trial / NCT04607525

Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy

NCT04607525 ↗

Phase 4 Completed 40 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

There is no clear consensus among neuroanesthesiologists regarding which anesthetic regimen is optimal for craniotomy. Propofol and short-acting opioids (such as remifentanil, fentanyl, or sufentanil) are commonly used. However, use of opioids is associated with increased risk of respiratory depression and postoperative nausea and vomiting. Dexmedetomidine is a highly selective α2-adrenoreceptor agonist that has been considered as a useful and safe adjunct to anesthesia for various surgical procedures

Timeline

Start
2020-11-21
Primary completion
2021-01-20
Completion
2021-01-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Other

Indications